Clinical and economic impact of molecular testing for BRAF fusion in pediatric low-grade Glioma

Clinical and economic impact of molecular testing for BRAF fusion in pediatric low-grade Glioma

Abstract Background Treatment personalization via tumor molecular testing holds promise for improving outcomes for patients with pediatric low-grade glioma (PLGG). We evaluate the health economic impact of employing tumor molecular testing to guide treatment for patients diagnosed with PLGG, particu...

Full description

Bibliographic Details
Main Authors: Juan David Rios, Russanthy Velummailum, Julie Bennett, Liana Nobre, Derek S. Tsang, Eric Bouffet, Cynthia Hawkins, Uri Tabori, Avram Denburg, Petros Pechlivanoglou
Format: Article
Language:English
Published: BMC 2022-01-01
Series:BMC Pediatrics
Subjects:
Pediatric low-grade Glioma
Health economics
Cost-effectiveness
Health technology evaluation
Precision medicine
Molecular testing
Online Access:https://doi.org/10.1186/s12887-021-03069-1

Internet

https://doi.org/10.1186/s12887-021-03069-1

Similar Items